Vnitr Lek 2023, 69(4):270-273 | DOI: 10.36290/vnl.2023.051

News in diabetology 2022

Milan Flekač
Diabetologické centrum VFN v Praze

The use of new antidiabetic drugs in clinical practice in the last two decades has completely changed the Type 2 diabetes management. Following the results of new clinical trials, international recommendations for the treatment of diabetes were regularly modified. In the field of Type 1 diabetes, new technologies have appeared, such as smart insulin pens. We can await once weekly insulins and dual GLP-1 and GIP analogues in the near future.

Keywords: GLP-1 RA, GIP, SGLT2 inhibitors, heart failure, chronic kidney disease, weekly insulin, diabetes management consensus.

Accepted: May 31, 2023; Published: June 22, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Flekač M. News in diabetology 2022. Vnitr Lek. 2023;69(4):270-273. doi: 10.36290/vnl.2023.051.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Melanie J, Davies J, et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 1. November 2022; 45(11):2753-2786. Go to original source... Go to PubMed...
    2. Paluch AE, et al. Daily steps and all­‑cause mortality: a meta­‑analysis of 15 international cohorts. Lancet Public Health. 2022;7(3):219-228. Go to original source... Go to PubMed...
    3. Solomon SD, et al. DELIVER Trial Committees and Investigators. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022 Sep 22;387(12):1089-1098. Go to original source... Go to PubMed...
    4. Herrington WG, et al. Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2023 Jan 12;388(2):117-127. Go to original source...
    5. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. Go to original source...
    6. Bajaj HS, et al. Switching to Once­‑Weekly Insulin Icodec Versus Once­‑Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial. Diabetes Care. 2021 Jul;44(7):1586-1594. doi: 10.2337/dc20-2877. Go to original source... Go to PubMed...
    7. Ekberg NR, et al. Smart pen exposes missed basal insulin injections and reveals the impact on glycemic control in adults with type 1 diabetes. J Diabetes Sci Technol. 2022 Jul 1. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.